TB Archives – Treatment Action Group

Statement from TAG’s TB Project on Today’s WHO Global TB Report

October 14, 2021
Dorrit Walsh

Today's Global TB Report from WHO confirms our worst expectations for how COVID-19 has set back the global TB response. The pandemic has reversed an entire generation of progress. The first year-on-year increase in TB deaths since 2005 is devastating.

Cover Of October 2021 TAGline - Title Is "delivering On The Promise Of Long-acting Formulations, And The Image Shows Many Calendar Sheets With The Names Of Months To Indicate That These Are Long-acting Technologies

TAGline October 2021

October 7, 2021
Dorrit Walsh

Delivering on the Promise of Long-Acting Forumulations delves deep into the development of long-acting formulations for the treatment and prevention of infectious diseases like HIV, tuberculosis, hepatitis C, and malaria. Long-acting medications have become common for conditions such as osteoporosis and schizophrenia, and they're even used for birth control.

First Page Of TAG And MSF Brief: Realizing Returns On U.S. Government Investment In GeneXpert Diagnostic Technologies

Realizing Returns on U.S. Government Investments in GeneXpert Diagnostic Technologies

September 15, 2021
Dorrit Walsh

GeneXpert diagnostic tests are essential tools in the struggle against COVID-19, tuberculosis, HIV, viral hepatitis, and other diseases. This brief outlines actionable steps the U.S. government can take to hold Cepheid accountable for transparent, fair, and equitable pricing of GeneXpert tests.

Development & Grant Officer

September 9, 2021
Dorrit Walsh

TAG is seeking a dynamic, highly motivated, and organized Development & Grant Officer to support grant and fundraising efforts.

Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing

August 27, 2021
Dorrit Walsh

TAG’s comprehensive analysis found that the public invested at least $252 million USD in the research and development of GeneXpert diagnostic technology, which stands in stark contrast to the lack of affordable pricing and favorable service and maintenance terms from the diagnostics company Cepheid.

2021 Pipeline Report

July 16, 2021
Dorrit Walsh

Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

TAG Testimonies on Funding Priorities FY22 to Senate LHHS and Related Agencies

July 9, 2021
Dorrit Walsh

On June 24, TAG submitted testimony to the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies outlining funding priorities for fiscal year 2022.

TAG Celebrates TB Advocacy Award for Senior Policy Officer Elizabeth Lovinger

June 25, 2021
Dorrit Walsh

TAG joins the U.S. National TB Controllers Association (NTCA) in celebrating our dedicated and brilliant Senior Government Relations and Policy Officer, Elizabeth (Lizzy) Lovinger, who today received the 2021 Charles DeGraw TB Advocacy Award.

Research in Action Awards 2021

June 16, 2021
Dorrit Walsh

Save the date for Tuesday, November 16, 2021! TAG’s 2021 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world. This year we’ll once again gather virtually to ensure this year’s event is safe and open for participation to our allies and friends across the U.S. and world.

2020 Annual Report

June 4, 2021
Dorrit Walsh

As the HIV epidemic changes over time, and new pandemics continue to emerge, TAG continues to evolve while remaining true to our activist roots. We partner with the most affected communities in the U.S. and around the world.